|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| C07K 14/755 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61K 47/62 | (2017.01) |
| (11) | Number of the document | 2804623 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13735649.9 |
| Date of filing the European patent application | 2013-01-12 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation | 2019-12-10 |
| (86) | Number | PCT/US2013/021330 |
| Date | 2013-01-12 |
| (87) | Number | WO 2013/106787 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261586099 P | 2012-01-12 | US | |
| 201261586654 P | 2012-01-13 | US | |
| 201261667901 P | 2012-07-03 | US | |
| 201261734954 P | 2012-12-07 | US |
| (72) |
CHHABRA, Ekta, Seth, US
LIU, Tongyao, US
PETERS, Robert, US
JIANG, Haiyan, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Chimeriniai VIII faktoriaus polipeptidai ir jų panaudojimas |
| CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-04 | 14 | 289.00 EUR |
| 2027-01-12 |